Sadie Whittaker

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Sadie Whittaker, PhD
Sadie Whittaker, PhD

Dr. Sadie Whittaker, is the Chief Scientific Officer of Solve ME/CFS Initiative (SMCI). She received her PhD in molecular biology at University of Birmingham, UK, and her BSc in Biochemistry from University of Leeds, UK. She worked first as a medical writer for Amgen before rising to the Director of Clinical Development and finally to US Medical Lead for Biosimilars there. Thereafter, she founded ScienceOne, where she served as CEO.

Dr. Whittaker joined Solve ME/CFS Initiative (SMCI) in May 2018, where she manages the Ramsay grants and serves as SMCI’s liaison with the National Institutes of Health (NIH) Collaborative Research Centers (CRCs) and Data Management Coordination Center (DMCC).

Notable studies[edit | edit source]

Advocacy[edit | edit source]

Open letter to The Lancet[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]